Search - tctmd.com

Displaying 101 - 120 of 408

Sort: Relevancy | Date

News Industry News

BioVentrix Announces Milestone Achievement of its First Interventional Heart Failure Procedure for LV Volume Reduction in a Pre-Clinical Mode

December 08, 2015

News Industry News

Regeneron and Sanofi Announce 18,000-Patient ODYSSEY OUTCOMES Trial of Praluent® Injection Fully Enrolled

November 23, 2015

News Daily News

Post-PCI Neurological Events, Though Infrequent, Continue to Carry ‘Abysmal’ Consequences

Todd Neale

November 22, 2015

News Daily News

专家们就指南推荐的多支冠脉病变患者护理方法的优点进行辩论

L.A. McKeown

November 17, 2015

News Industry News

New Publication Featuring GlycoMark® Test Highlights Association of Hyperglycemic Excursions With Cardiovascular Outcomes And Mortality

November 17, 2015

News Daily News

Los Expertos Debaten los Tratamientos basados en las Directrices en Pacientes con Enfermedad Multivaso

L.A. McKeown

November 17, 2015

News Daily News

Experts Debate Merits of Guideline-Directed Care for Patients With Multivessel Disease

L.A. McKeown

November 17, 2015

Presentation

Effect of PCI on Long-term Survivalin Patients With Stable Ischemic Heart Disease

Presenter: Steven P. Sedlis

November 10, 2015

News Daily News

COURAGE at 15 Years: Still No Survival Advantage for PCI

L.A. McKeown

November 10, 2015

News Daily News

Post-TAVR Myocardial Injury Linked to Mortality

Caitlin E. Cox

November 02, 2015

News Industry News

First Patient Successfully Enrolled into ROADSTER 2 Transcarotid Artery Revascularization (TCAR) Study

November 02, 2015

News Opinion Editor's Corner TCT 2015

My Takeaways From TCT 2015

Shelley Wood

October 20, 2015

Presentation TCT 2015

TCT 32: Percutaneous Ventricular Restoration (PVR) Therapy Using the Parachute Device in Patients With Ischemic Dilated Heart Failure Two-Year Results of the PARACHUTE III European Postmarket Trial

Presenter: John P. Cheatham, Carlos Pedra, Ulrich Schaefer

October 13, 2015

Presentation TCT 2015

Ischemic Heart Disease and Acute Coronary Syndrome

Presenter: Hugh J. Linnehan, Bernard J. Gersh

October 13, 2015

Presentation TCT 2015

Adjuvant Pharmacotherapy With Ranolazine In Patients With Ischemic Heart Disease

Presenter: Bernard J. Gersh, Stephen D. Wiviott, Giora Weisz

October 13, 2015

News Industry News

Medical Therapy With Ranolazine Did Not Reduce Adverse Events In Patients With Persistent Untreated Heart Artery Blockages After Percutaneous Coronary Intervention

October 13, 2015

Presentation TCT 2015

The Netherlands Presents: A Case Demonstration of Coronary Flow Capacity to Document Ischemic Heart Disease

Presenter: Morton J. Kern, Jan J. Piek, Tim P. van de Hoef

October 12, 2015

Presentation TCT 2015

Debate: Should Most Patients With Stable Ischemic Heart Disease, Moderate or Greater Ischemia, and Controllable Symptoms Undergo Revascularization? Yes, an Evidence-Based Position!

Presenter: Kevin J. Beatt, Craig R. Smith, Gregg W. Stone

October 11, 2015

Presentation TCT 2015

Debate: Should Most Patients With Stable Ischemic Heart Disease, Moderate or Greater Ischemia, and Controllable Symptoms Undergo Revascularization? The Data Says Not as a First-Line Therapy!

Presenter: Kevin J. Beatt, Craig R. Smith, David J. Maron

October 11, 2015

News Daily News

Contrary to Expectations, Study Finds No Sex Difference in Coronary Microvascular Dysfunction

Yael L. Maxwell

September 23, 2015

Advertisement

BioVentrix Announces Milestone Achievement of its First Interventional Heart Failure Procedure for LV Volume Reduction in a Pre-Clinical Mode

Regeneron and Sanofi Announce 18,000-Patient ODYSSEY OUTCOMES Trial of Praluent® Injection Fully Enrolled

Post-PCI Neurological Events, Though Infrequent, Continue to Carry ‘Abysmal’ Consequences

专家们就指南推荐的多支冠脉病变患者护理方法的优点进行辩论

New Publication Featuring GlycoMark® Test Highlights Association of Hyperglycemic Excursions With Cardiovascular Outcomes And Mortality

Los Expertos Debaten los Tratamientos basados en las Directrices en Pacientes con Enfermedad Multivaso

Experts Debate Merits of Guideline-Directed Care for Patients With Multivessel Disease

Effect of PCI on Long-term Survivalin Patients With Stable Ischemic Heart Disease

COURAGE at 15 Years: Still No Survival Advantage for PCI

Post-TAVR Myocardial Injury Linked to Mortality

First Patient Successfully Enrolled into ROADSTER 2 Transcarotid Artery Revascularization (TCAR) Study

My Takeaways From TCT 2015

TCT 32: Percutaneous Ventricular Restoration (PVR) Therapy Using the Parachute Device in Patients With Ischemic Dilated Heart Failure Two-Year Results of the PARACHUTE III European Postmarket Trial

Ischemic Heart Disease and Acute Coronary Syndrome

Adjuvant Pharmacotherapy With Ranolazine In Patients With Ischemic Heart Disease

Medical Therapy With Ranolazine Did Not Reduce Adverse Events In Patients With Persistent Untreated Heart Artery Blockages After Percutaneous Coronary Intervention

The Netherlands Presents: A Case Demonstration of Coronary Flow Capacity to Document Ischemic Heart Disease

Debate: Should Most Patients With Stable Ischemic Heart Disease, Moderate or Greater Ischemia, and Controllable Symptoms Undergo Revascularization? Yes, an Evidence-Based Position!

Debate: Should Most Patients With Stable Ischemic Heart Disease, Moderate or Greater Ischemia, and Controllable Symptoms Undergo Revascularization? The Data Says Not as a First-Line Therapy!

Contrary to Expectations, Study Finds No Sex Difference in Coronary Microvascular Dysfunction

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content